p1 coding sequences tatg Search Results


99
Thermo Fisher gene exp rpl13a hs04194366 g1
Gene Exp Rpl13a Hs04194366 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/schmidt_hutten_lena__2023__regulation_of_the_l_arginine_adma_no_pathway_in_coronary_and_pulmonary_endothelial_and_alveolar-493-32--1?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
gene exp rpl13a hs04194366 g1 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

90
Merck KGaA tat-cre recombinase
Tat Cre Recombinase, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/10__21203_slash_rs__3__rs___3896294_slash_v1-197-16-25?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
tat-cre recombinase - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Merck & Co tat cre recombinase 1500u
Tat Cre Recombinase 1500u, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/pm41423470-244-2-5?v=Merck+%26+Co
Average 86 stars, based on 1 article reviews
tat cre recombinase 1500u - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
ChinaPeptide Co Ltd tat-p2
Tat P2, supplied by ChinaPeptide Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/pmc06004018-272-4-20?v=ChinaPeptide+Co+Ltd
Average 90 stars, based on 1 article reviews
tat-p2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Metabion International AG stn p1-forward primer
Stn P1 Forward Primer, supplied by Metabion International AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/10__3201_slash_eid2809__nn2809-9110-33-60?v=Metabion+International+AG
Average 90 stars, based on 1 article reviews
stn p1-forward primer - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ChinaPeptide Co Ltd peptide synthesis tat2-p1
Peptide Synthesis Tat2 P1, supplied by ChinaPeptide Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/pm35922403-163-0-14?v=ChinaPeptide+Co+Ltd
Average 90 stars, based on 1 article reviews
peptide synthesis tat2-p1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
Addgene inc tat cre recombinase
Tat Cre Recombinase, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/pmc08639150-591-11-3?v=Addgene+inc
Average 93 stars, based on 1 article reviews
tat cre recombinase - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
ChinaPeptide Co Ltd tat-p1
Tat P1, supplied by ChinaPeptide Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/pmc09349215-215-0-12?v=ChinaPeptide+Co+Ltd
Average 90 stars, based on 1 article reviews
tat-p1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

98
Thermo Fisher gene exp bcl2 rn99999125 m1
Gene Exp Bcl2 Rn99999125 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/ppr0369338-76-268--1?v=Thermo+Fisher
Average 98 stars, based on 1 article reviews
gene exp bcl2 rn99999125 m1 - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier

96
Addgene inc recombinant tat cre cre recombinase dna
Figure 2. <t>Recombinant</t> TAT-Cre exhibits <t>recombinase</t> activity on endometrial epithelial cells in vitro and in vivo. A) Representative images and quantifi- cation of tdTomato positive (mT) or GFP positive (mG) monolayer endometrial epithelial cells isolated from mT/mGf/f mouse ears 4 days after being treated with the following TAT-CRE concentrations: 0 (0), 17.6 (D1), 35.2 (D2), 88 (D3), 176 (D4), and 352 μg mL−1 (D5). Data come from n = 3 indepen- dent experiments. *p<0.5 ****p<0.0001, using a one-way ANOVA analysis, followed by a Bonferroni multiple comparison test. B) Representative images and quantification of tdTomato positive (mT) or GFP positive (mG) organoids of endometrial epithelial cells isolated from mT/mGf/f mouse ears 4 days after being treated with the following TAT-Cre concentrations: 0 (0), 17.6 (D1), 35.2 (D2), 88 (D3), 176 (D4), and 352 μg mL−1 (D5). Data come from n = 3 independent experiments. *p<0.5 ****p<0.0001, using a one-way ANOVA analysis, followed by a Bonferroni multiple comparison test. C) Diagram depicting intrauterine administration of 88 μg of recombinant TAT-Cre per uterine horn of mT/mGf/f mouse. D) Right, representative images images obtained from red (tdTomato) and green (mGFP) fluorescence at 4X of mT/mGf/f endometria 4 months after intravaginal administration of 88 μg of recombinant TAT-Cre. Scale bar at 2 mm. Left, 20x magnification of the indicated framed areas where the membranous mGFP labeling is appreciated in endometrial cells 4 month after TAT-Cre-mediated gene ablation. E) Representative images of GFP immunohistochemistry on endometrial tissue sections from mT/mGf/f endometria 4 months after intravaginal administration of 88 μg of recombinant TAT-Cre showing areas of high recombination (left image) or low recombination (right image). Table shows the average of the percent of GFP positive (GFP+) on epithelial and stromal compartment. Cells were scored from at least 10 sections from 3 different areas from 3 independent mice.
Recombinant Tat Cre Cre Recombinase Dna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/pm37749866-302-5-16?v=Addgene+inc
Average 96 stars, based on 1 article reviews
recombinant tat cre cre recombinase dna - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
Shanghai Genon Bio engineering Co Ltd tat-cre recombinase
Figure 2. <t>Recombinant</t> TAT-Cre exhibits <t>recombinase</t> activity on endometrial epithelial cells in vitro and in vivo. A) Representative images and quantifi- cation of tdTomato positive (mT) or GFP positive (mG) monolayer endometrial epithelial cells isolated from mT/mGf/f mouse ears 4 days after being treated with the following TAT-CRE concentrations: 0 (0), 17.6 (D1), 35.2 (D2), 88 (D3), 176 (D4), and 352 μg mL−1 (D5). Data come from n = 3 indepen- dent experiments. *p<0.5 ****p<0.0001, using a one-way ANOVA analysis, followed by a Bonferroni multiple comparison test. B) Representative images and quantification of tdTomato positive (mT) or GFP positive (mG) organoids of endometrial epithelial cells isolated from mT/mGf/f mouse ears 4 days after being treated with the following TAT-Cre concentrations: 0 (0), 17.6 (D1), 35.2 (D2), 88 (D3), 176 (D4), and 352 μg mL−1 (D5). Data come from n = 3 independent experiments. *p<0.5 ****p<0.0001, using a one-way ANOVA analysis, followed by a Bonferroni multiple comparison test. C) Diagram depicting intrauterine administration of 88 μg of recombinant TAT-Cre per uterine horn of mT/mGf/f mouse. D) Right, representative images images obtained from red (tdTomato) and green (mGFP) fluorescence at 4X of mT/mGf/f endometria 4 months after intravaginal administration of 88 μg of recombinant TAT-Cre. Scale bar at 2 mm. Left, 20x magnification of the indicated framed areas where the membranous mGFP labeling is appreciated in endometrial cells 4 month after TAT-Cre-mediated gene ablation. E) Representative images of GFP immunohistochemistry on endometrial tissue sections from mT/mGf/f endometria 4 months after intravaginal administration of 88 μg of recombinant TAT-Cre showing areas of high recombination (left image) or low recombination (right image). Table shows the average of the percent of GFP positive (GFP+) on epithelial and stromal compartment. Cells were scored from at least 10 sections from 3 different areas from 3 independent mice.
Tat Cre Recombinase, supplied by Shanghai Genon Bio engineering Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/pm18547746-2-26-88?v=Shanghai+Genon+Bio+engineering+Co+Ltd
Average 90 stars, based on 1 article reviews
tat-cre recombinase - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

96
New England Biolabs tat cre recombinase protein
Figure 2. <t>Recombinant</t> TAT-Cre exhibits <t>recombinase</t> activity on endometrial epithelial cells in vitro and in vivo. A) Representative images and quantifi- cation of tdTomato positive (mT) or GFP positive (mG) monolayer endometrial epithelial cells isolated from mT/mGf/f mouse ears 4 days after being treated with the following TAT-CRE concentrations: 0 (0), 17.6 (D1), 35.2 (D2), 88 (D3), 176 (D4), and 352 μg mL−1 (D5). Data come from n = 3 indepen- dent experiments. *p<0.5 ****p<0.0001, using a one-way ANOVA analysis, followed by a Bonferroni multiple comparison test. B) Representative images and quantification of tdTomato positive (mT) or GFP positive (mG) organoids of endometrial epithelial cells isolated from mT/mGf/f mouse ears 4 days after being treated with the following TAT-Cre concentrations: 0 (0), 17.6 (D1), 35.2 (D2), 88 (D3), 176 (D4), and 352 μg mL−1 (D5). Data come from n = 3 independent experiments. *p<0.5 ****p<0.0001, using a one-way ANOVA analysis, followed by a Bonferroni multiple comparison test. C) Diagram depicting intrauterine administration of 88 μg of recombinant TAT-Cre per uterine horn of mT/mGf/f mouse. D) Right, representative images images obtained from red (tdTomato) and green (mGFP) fluorescence at 4X of mT/mGf/f endometria 4 months after intravaginal administration of 88 μg of recombinant TAT-Cre. Scale bar at 2 mm. Left, 20x magnification of the indicated framed areas where the membranous mGFP labeling is appreciated in endometrial cells 4 month after TAT-Cre-mediated gene ablation. E) Representative images of GFP immunohistochemistry on endometrial tissue sections from mT/mGf/f endometria 4 months after intravaginal administration of 88 μg of recombinant TAT-Cre showing areas of high recombination (left image) or low recombination (right image). Table shows the average of the percent of GFP positive (GFP+) on epithelial and stromal compartment. Cells were scored from at least 10 sections from 3 different areas from 3 independent mice.
Tat Cre Recombinase Protein, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p1+coding+sequences+tatg/pm38091951-282-145-174?v=New+England+Biolabs
Average 96 stars, based on 1 article reviews
tat cre recombinase protein - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

Image Search Results


Figure 2. Recombinant TAT-Cre exhibits recombinase activity on endometrial epithelial cells in vitro and in vivo. A) Representative images and quantifi- cation of tdTomato positive (mT) or GFP positive (mG) monolayer endometrial epithelial cells isolated from mT/mGf/f mouse ears 4 days after being treated with the following TAT-CRE concentrations: 0 (0), 17.6 (D1), 35.2 (D2), 88 (D3), 176 (D4), and 352 μg mL−1 (D5). Data come from n = 3 indepen- dent experiments. *p<0.5 ****p<0.0001, using a one-way ANOVA analysis, followed by a Bonferroni multiple comparison test. B) Representative images and quantification of tdTomato positive (mT) or GFP positive (mG) organoids of endometrial epithelial cells isolated from mT/mGf/f mouse ears 4 days after being treated with the following TAT-Cre concentrations: 0 (0), 17.6 (D1), 35.2 (D2), 88 (D3), 176 (D4), and 352 μg mL−1 (D5). Data come from n = 3 independent experiments. *p<0.5 ****p<0.0001, using a one-way ANOVA analysis, followed by a Bonferroni multiple comparison test. C) Diagram depicting intrauterine administration of 88 μg of recombinant TAT-Cre per uterine horn of mT/mGf/f mouse. D) Right, representative images images obtained from red (tdTomato) and green (mGFP) fluorescence at 4X of mT/mGf/f endometria 4 months after intravaginal administration of 88 μg of recombinant TAT-Cre. Scale bar at 2 mm. Left, 20x magnification of the indicated framed areas where the membranous mGFP labeling is appreciated in endometrial cells 4 month after TAT-Cre-mediated gene ablation. E) Representative images of GFP immunohistochemistry on endometrial tissue sections from mT/mGf/f endometria 4 months after intravaginal administration of 88 μg of recombinant TAT-Cre showing areas of high recombination (left image) or low recombination (right image). Table shows the average of the percent of GFP positive (GFP+) on epithelial and stromal compartment. Cells were scored from at least 10 sections from 3 different areas from 3 independent mice.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Article Title: In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers.

doi: 10.1002/advs.202303134

Figure Lengend Snippet: Figure 2. Recombinant TAT-Cre exhibits recombinase activity on endometrial epithelial cells in vitro and in vivo. A) Representative images and quantifi- cation of tdTomato positive (mT) or GFP positive (mG) monolayer endometrial epithelial cells isolated from mT/mGf/f mouse ears 4 days after being treated with the following TAT-CRE concentrations: 0 (0), 17.6 (D1), 35.2 (D2), 88 (D3), 176 (D4), and 352 μg mL−1 (D5). Data come from n = 3 indepen- dent experiments. *p<0.5 ****p<0.0001, using a one-way ANOVA analysis, followed by a Bonferroni multiple comparison test. B) Representative images and quantification of tdTomato positive (mT) or GFP positive (mG) organoids of endometrial epithelial cells isolated from mT/mGf/f mouse ears 4 days after being treated with the following TAT-Cre concentrations: 0 (0), 17.6 (D1), 35.2 (D2), 88 (D3), 176 (D4), and 352 μg mL−1 (D5). Data come from n = 3 independent experiments. *p<0.5 ****p<0.0001, using a one-way ANOVA analysis, followed by a Bonferroni multiple comparison test. C) Diagram depicting intrauterine administration of 88 μg of recombinant TAT-Cre per uterine horn of mT/mGf/f mouse. D) Right, representative images images obtained from red (tdTomato) and green (mGFP) fluorescence at 4X of mT/mGf/f endometria 4 months after intravaginal administration of 88 μg of recombinant TAT-Cre. Scale bar at 2 mm. Left, 20x magnification of the indicated framed areas where the membranous mGFP labeling is appreciated in endometrial cells 4 month after TAT-Cre-mediated gene ablation. E) Representative images of GFP immunohistochemistry on endometrial tissue sections from mT/mGf/f endometria 4 months after intravaginal administration of 88 μg of recombinant TAT-Cre showing areas of high recombination (left image) or low recombination (right image). Table shows the average of the percent of GFP positive (GFP+) on epithelial and stromal compartment. Cells were scored from at least 10 sections from 3 different areas from 3 independent mice.

Article Snippet: Cloning, Expression, and Isolation of Recombinant TAT-CRE: Cre recombinase DNA was amplified by PCR using pCAG-Cre (Addgene #13 775) as nloaded from https://onlinelibrary.w iley.com /doi/10.1002/advs.202303134 by C A PE S, W iley O nline L ibrary on [11/01/2024].

Techniques: Recombinant, Activity Assay, In Vitro, In Vivo, Isolation, Comparison, Labeling, Immunohistochemistry